Per Odin

Dopamine agonist serum concentrations and impulse control disorders in Parkinson's disease

M. Toft, E. Størset, E. Dietrichs, 2023, European journal of neurology.

Clinical risk–benefit assessment of dopamine agonists

K. Chaudhuri, J. C. Möller, P. Odin, 2008, European journal of neurology.

Current options and future possibilities for the treatment of dyskinesia and motor fluctuations in Parkinson's disease.

M. Cenci, P. Odin, K. Ohlin, 2011, CNS & neurological disorders drug targets.